论文部分内容阅读
目的分析并总结阿司匹林、氯吡格雷以及阿托伐他汀钙在不稳定型心绞痛治疗过程中的效果与安全性。方法对本院自2008年11月至2010年11月期间入院接受阿司匹林、氯吡格雷以及阿托伐他汀钙治疗的102例不稳定型心绞痛患者进行回顾性分析。结果治疗组与对照组显效病例数分别为37例和28例;有效病例数分别为10例和11例;无效病例数分别为4例和12例,两组的总有效率分别为93.2%和77.4%;两组患者在治疗前后组内与组间进行对比,均差异有统计学意义(P<0.05),均具统计学意义。结论阿司匹林、氯吡格雷以及阿托伐他汀钙在治疗不稳定型心绞痛方面安全可靠,疗效显著,值得临床广泛推广,具有广阔的前景。
Objective To analyze and summarize the efficacy and safety of aspirin, clopidogrel and atorvastatin calcium in the treatment of unstable angina pectoris. Methods A retrospective analysis of 102 patients with unstable angina who were admitted to our hospital from November 2008 to November 2010 with aspirin, clopidogrel and atorvastatin calcium was conducted. Results The number of effective cases in treatment group and control group were 37 cases and 28 cases respectively. The effective cases were 10 cases and 11 cases. The invalid cases were 4 cases and 12 cases. The total effective rates were 93.2% 77.4% respectively. There was significant difference between the two groups before and after treatment (P <0.05), both of which were statistically significant. Conclusion Aspirin, clopidogrel and atorvastatin calcium are safe and reliable in the treatment of unstable angina pectoris and have significant curative effect. It is worthy of widespread clinical application and has broad prospects.